Manufacturing

Articles

GE Healthcare will equip Cellular Biomedicine Group's cell therapy manufacturing facility in Shanghai, China, with its FlexFactory single-use platform, designed to speed up cell therapy manufacturing timelines.

GE Healthcare to Equip Cell Therapy Manufacturing Facility with Single-Use Platform

Sartorius Stedim Biotech will equip Abzena’s contract development and manufacturing facilities in Bristol, PA, and San Diego, CA, with single-use equipment and scale-up technologies.

Sartorius Stedim Biotech to Equip Abzena Single-Use Manufacturing Sites

The companies aim to develop a potential zinc finger protein transcription factor-based gene therapy for treating Lou Gehrig’s disease.

Pfizer and Sangamo Partner on Gene Therapy for Lou Gehrig's Disease

The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.

Wuxi Griffin Opens a New Aseptic Fill Finish Facility

Gregg Johnson is global senior product manager for Masterflex and Ismatec Product Lines, Cole-Parmer.

Proper selection and installation optimizes fluid system performance.

Selecting and Installing Peristaltic Pump Tubing

FDA has approved a new gene therapy for treating patients born with a rare, inherited vision loss.

FDA Approves Spark Therapeutics’ Gene Therapy for Inherited Vision Loss

MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.

MilliporeSigma to Offer End-to-End MAb Manufacturing Using the iCON Platform

BioTek Instruments has released a second edition of its BioSpa software that now offers users a simplified but effective interface for kinetic imaging or detection workflows.

BioTek Adds “OnDemand” Mode to BioSpa Software

Sanofi Genzyme and its partner, Alnylam Pharmaceuticals, have filed a marketing authorization application with EMA for an investigational RNAi therapeutic for treating a genetic-based disease.

Sanofi and Alnylam Seek EMA Approval for RNAi Therapeutic

The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.

Manufacturing, Biologic Drugs